Can Self-Compassion training boost mental health in transgender youth?
NCT ID NCT06409975
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study explores whether an 8-week virtual mindful self-compassion program is practical and well-received by transgender and nonbinary young adults. Participants attend weekly 2.5-hour online classes plus a 4-hour retreat, practice daily exercises, and complete surveys over several months. The goal is to see if this approach is feasible and acceptable, not yet to measure its effectiveness.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Mindful Self-Compassion (MSC) program
- What this could lead to
- If successful, this could provide a tailored mental health support option for transgender and nonbinary young adults, potentially improving emotional well-being.
- What could go wrong
- This is a small, early feasibility study with no control group, so results may not prove effectiveness. The program requires a significant time commitment, which may limit participation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
N/A-- All study activities being conducted virtually
RECRUITINGProvidence, Rhode Island, 02903, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test